Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Loading…
Population‐based cellular kinetic characterization of ciltacabtagene autoleucel in subjects with relapsed or refractory multiple myeloma
Wu, Liviawati S., Su, Yaming, Li, Claire, Zhou, Wangda, Jackson, Carolyn C., Sun, Yu‐Nien, Zhou, Honghui
Published in Clinical and translational science (01.12.2022)
Published in Clinical and translational science (01.12.2022)
Get full text
Journal Article
Loading…
Cost-effectiveness of Daratumumab-based Triplet Therapies in Patients With Relapsed or Refractory Multiple Myeloma
Zhang, Tian-tian, Wang, Sen, Wan, Ning, Zhang, Li, Zhang, Zugui, Jiang, Jie
Published in Clinical therapeutics (01.07.2018)
Published in Clinical therapeutics (01.07.2018)
Get full text
Journal Article
Loading…
Three-Year Follow-up on Efficacy and Safety Results from Phase 1 Lummicar Study 1 of Zevorcabtagene Autoleucel in Chinese Patients with Relapsed or Refractory Multiple Myeloma
Fu, Chengcheng, Chen, Wenming, Cai, Zhen, Yan, Lingzhi, Wang, Huijuan, Shang, Jingjing, Wu, Yin, Yan, Shuang, Gao, Wen, Shi, Xiaolan, Han, Xiaoyan, Tang, Fang, Zheng, Gaofeng, Wen, Yanling, Meng, Xingxing, Zheng, Wei, Wang, Huamao, Li, Zonghai
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Loading…
Soluble B-Cell Maturation Antigen As a Disease Biomarker in Relapsed or Refractory Multiple Myeloma (RRMM): Evaluation from Elranatamab (ELRA) Magnetismm Studies
Elmeliegy, Mohamed, Kei Lon, Hoi, Wang, Diane, An Ma, Wei, King, Lindsay, Viqueira, Andrea, Czibere, Akos
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Loading…
A phase 1 clinical trial of the repurposable acetyllysine mimetic, n-methyl-2-pyrrolidone (NMP), in relapsed or refractory multiple myeloma
Jake Shortt, Galettis, Peter, Cheah, Chan Y., Davis, Joanne, Ludford-Menting, Mandy, Link, Emma K., Martin, Jennifer H., Koldej, Rachel, Ritchie, David
Published in Clinical epigenetics (28.01.2023)
Published in Clinical epigenetics (28.01.2023)
Get full text
Journal Article
Loading…
GRP78-directed immunotherapy in relapsed or refractory multiple myeloma - results from a phase 1 trial with the monoclonal immunoglobulin M antibody PAT-SM6
Rasche, L., Duell, J., Castro, I. C., Dubljevic, V., Chatterjee, M., Knop, S., Hensel, F., Rosenwald, A., Einsele, H., Topp, M. S., Brandlein, S.
Published in Haematologica (Roma) (01.03.2015)
Published in Haematologica (Roma) (01.03.2015)
Get full text
Journal Article
Loading…
Fractionated Dosing of CLR 131 in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)
Ailawadhi, Sikander, Stiff, Patrick J., Ibrahim, Emad, Vallurupalli, Anusha, Cull, Elizabeth H., Green, Damian J., Oliver, Kate, Longcor, Jarrod
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Loading…
Biomarker Correlates of Response to Ciltacabtagene Autoleucel in Patients with Relapsed or Refractory Multiple Myeloma from CARTITUDE-1, a Phase 1b/2 Open-Label Study, at the ~3 Year Follow-up
Montes de Oca, Rocio, Gu, Junchen, Zhao, Hao, Zelinsky, Kathy, Wu, Dianna, Davis, Cuc, Patel, Jaymala, Foulk, Brad, Boominathan, Rengasamy, Lau, Onsay, Smirnov, Denis, Lin, Yi, Jagannath, Sundar, Cohen, Adam D., Haddish-Berhane, Nahor, Xu, Jean, Madduri, Deepu, Stevens, An-Sofie, Jackson, Carolyn Chang, Schecter, Jordan M., Banerjee, Arnob, Geng, Dong, Zhu, Jieqing, Xu, Sifan, Zudaire, Enrique
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Loading…
SOR-CART-MM-001 Study: A Phase I, Open-Label, Dose-Escalation, Pharmacokinetic, and Pharmacodynamic Study of Safety and Efficacy of CAR2 Anti-CD38 A2 CAR-T Cells in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)
Stadtmauer, Edward A., Elghawy, Omar, Roberts, Todd F., Madduri, Deepu, Ailawadhi, Sikander, Royal, Mike, Yan, Ying
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Loading…
Safety and tolerability of BION-1301 in adults with relapsed or refractory multiple myeloma
Bensinger, William, Raptis, Anastasios, Berenson, James R., Spira, Alexander I., Nooka, Ajay K., Chaudhry, Maria, van Zandvoort, Peter, Nair, Nitya, Lo, Jeannette, Elassaiss-Schaap, Jeroen, Walling, Jackie, Hari, Parameswaran
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Loading…
Pharmacokinetics, pharmacodynamics, safety, and tolerability of BION-1301 in adults with relapsed or refractory multiple myeloma
Elassaiss-Schaap, Jeroen, van Zandvoort, Peter, Lo, Jeannette, Nair, Nitya, Walling, Jackie, Hari, Parameswaran, Bensinger, William
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Loading…
Safety and efficacy of pomalidomide, dexamethasone and pegylated liposomal doxorubicin for patients with relapsed or refractory multiple myeloma
Cohen, Alexa, Spektor, Tanya M., Stampleman, Laura, Bessudo, Alberto, Rosen, Peter J., Klein, Leonard M., Woliver, Thomas, Flam, Marshall, Eshaghian, Shahrooz, Nassir, Youram, Maluso, Tina, Swift, Regina A., Vescio, Robert, Berenson, James R.
Published in British journal of haematology (01.01.2018)
Published in British journal of haematology (01.01.2018)
Get full text
Journal Article
Loading…
Brief report: Clinical experiences after emergency use of daratumumab monotherapy for relapsed or refractory multiple myeloma in real practice
Park, Sung-Soo, Eom, Hyeon-Seok, Kim, Jin Seok, Koh, Youngil, Choi, Chul Won, Lee, Je-Jung, Kim, Kihyun, Suh, Cheolwon, Lee, Jae Hoon, Min, Chang-Ki
Published in Japanese journal of clinical oncology (01.01.2019)
Published in Japanese journal of clinical oncology (01.01.2019)
Get full text
Journal Article
Loading…
Immune Profiling of Relapsed or Refractory Multiple Myeloma Patients Treated with Pomalidomide and Low-Dose Dexamethasone in Combination with Daratumumab
Pierceall, William E., Bahlis, Nizar, Siegel, David S, Schiller, Gary J., Samaras, Christy J., Sebag, Michael, Berdeja, Jesus G., Ganguly, Siddhartha, Matous, Jeffrey V, Song, Kevin, Seet, Christopher S., Talamo, Giampaolo, Srinivas, Shanti, Acosta-Rivera, Mirelis, Bar, Michael, Quick, Donald P., Anz, Bertrand, Fonseca, Gustavo, Reece, Donna, Chung, Weiyuan, Serbina, Natalya, Zafar, Faiza, Agarwal, Amit, Thakurta, Anjan
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
Loading…
SGNBCMA-001: A phase 1 study of SEA-BCMA, a non-fucosylated monoclonal antibody, in subjects with relapsed or refractory multiple myeloma
Abdallah, Al-Ola A., Hoffman, James Edward, Schroeder, Mark A., Jacquemont, Celine, Li, Hong, Wang, Yinghui, Van Epps, Heather, Campbell, Mary S.
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Loading…
Abstract 5182: Population pharmacokinetic modeling of ciltacabtagene autoleucel in subjects with relapsed or refractory multiple myeloma
Wu, Liviawati S., Su, Yaming, Li, Claire, Zhou, Wangda, Jackson, Carolyn, Sun, Yu-Nien, Zhou, Honghui
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article
Loading…
Abstract CT107: Phase I/II safety and pharmacokinetics of BION-1301 targeting APRIL, a proliferation-inducing ligand, in adults with relapsed or refractory multiple myeloma
Hari, Parameswaran, Raptis, Anastasios, Berenson, James, Spira, Alexander, Nooka, Ajay, Chaudhry, Maria, Nair, Nitya, Namini, Hamid, Walling, Jackie, Chapman, Deb, Bensinger, William
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article
Loading…
Efficacy of Anti-CD38 Monoclonal Antibodies for Relapsed or Refractory Multiple Myeloma in Stem Cell Transplant-Ineligible Patients Aged over 65 Years: A Propensity Score-Matched Study
Yamasaki, Satoshi, Hashiguchi, Michitoshi, Yoshida-Sakai, Nao, Jojima, Hiroto, Osaki, Koichi, Okamura, Takashi, Imamura, Yutaka
Published in Hematology reports (18.11.2024)
Published in Hematology reports (18.11.2024)
Get full text
Journal Article
Loading…
Randomized, Open-Label, Non-Inferiority, Phase 3 Study of Subcutaneous (SC) Versus Intravenous (IV) Daratumumab (DARA) Administration in Patients (Pts) with Relapsed or Refractory Multiple Myeloma (RRMM): Body Weight Subgroup Analysis of Columba
Mateos, Maria-Victoria, Usmani, Saad Z., Grosicki, Sebastian, Vorobyev, Vladimir I., Spicka, Ivan, Hungria, Vania T.M., Korenkova, Sibirina, Bahlis, Nizar, Flogegard, Max, Bladé, Joan, Moreau, Philippe, Kaiser, Martin F., Iida, Shinsuke, Laubach, Jacob P., Masterson, Tara, Lantz, Kristen Anne, O'Rourke, Lisa, Qin, Xiang, Parasrampuria, Dolly A., Heuck, Christoph, Qi, Ming, Nahi, Hareth
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Conference Proceeding